These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 25243742

  • 1. A differential role for CD248 (Endosialin) in PDGF-mediated skeletal muscle angiogenesis.
    Naylor AJ, McGettrick HM, Maynard WD, May P, Barone F, Croft AP, Egginton S, Buckley CD.
    PLoS One; 2014; 9(9):e107146. PubMed ID: 25243742
    [Abstract] [Full Text] [Related]

  • 2. CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism.
    Wilhelm A, Aldridge V, Haldar D, Naylor AJ, Weston CJ, Hedegaard D, Garg A, Fear J, Reynolds GM, Croft AP, Henderson NC, Buckley CD, Newsome PN.
    Gut; 2016 Jul; 65(7):1175-85. PubMed ID: 26078290
    [Abstract] [Full Text] [Related]

  • 3. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes.
    Ruan J, Luo M, Wang C, Fan L, Yang SN, Cardenas M, Geng H, Leonard JP, Melnick A, Cerchietti L, Hajjar KA.
    Blood; 2013 Jun 27; 121(26):5192-202. PubMed ID: 23632889
    [Abstract] [Full Text] [Related]

  • 4. Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function.
    Semela D, Das A, Langer D, Kang N, Leof E, Shah V.
    Gastroenterology; 2008 Aug 27; 135(2):671-9. PubMed ID: 18570897
    [Abstract] [Full Text] [Related]

  • 5. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
    Hasumi Y, Kłosowska-Wardega A, Furuhashi M, Ostman A, Heldin CH, Hellberg C.
    Int J Cancer; 2007 Dec 15; 121(12):2606-14. PubMed ID: 17691110
    [Abstract] [Full Text] [Related]

  • 6. Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling.
    Tomkowicz B, Rybinski K, Sebeck D, Sass P, Nicolaides NC, Grasso L, Zhou Y.
    Cancer Biol Ther; 2010 Jun 01; 9(11):908-15. PubMed ID: 20484976
    [Abstract] [Full Text] [Related]

  • 7. HIF-1alpha and HIF-2alpha play a central role in stretch-induced but not shear-stress-induced angiogenesis in rat skeletal muscle.
    Milkiewicz M, Doyle JL, Fudalewski T, Ispanovic E, Aghasi M, Haas TL.
    J Physiol; 2007 Sep 01; 583(Pt 2):753-66. PubMed ID: 17627993
    [Abstract] [Full Text] [Related]

  • 8. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
    Pietras K, Pahler J, Bergers G, Hanahan D.
    PLoS Med; 2008 Jan 29; 5(1):e19. PubMed ID: 18232728
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pericytes promote selective vessel regression to regulate vascular patterning.
    Simonavicius N, Ashenden M, van Weverwijk A, Lax S, Huso DL, Buckley CD, Huijbers IJ, Yarwood H, Isacke CM.
    Blood; 2012 Aug 16; 120(7):1516-27. PubMed ID: 22740442
    [Abstract] [Full Text] [Related]

  • 12. Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.
    Rybinski K, Imtiyaz HZ, Mittica B, Drozdowski B, Fulmer J, Furuuchi K, Fernando S, Henry M, Chao Q, Kline B, Albone E, Wustner J, Lin J, Nicolaides NC, Grasso L, Zhou Y.
    Oncotarget; 2015 Sep 22; 6(28):25429-40. PubMed ID: 26327620
    [Abstract] [Full Text] [Related]

  • 13. The mesenchymal stem cell marker CD248 (endosialin) is a negative regulator of bone formation in mice.
    Naylor AJ, Azzam E, Smith S, Croft A, Poyser C, Duffield JS, Huso DL, Gay S, Ospelt C, Cooper MS, Isacke C, Goodyear SR, Rogers MJ, Buckley CD.
    Arthritis Rheum; 2012 Oct 22; 64(10):3334-43. PubMed ID: 22674221
    [Abstract] [Full Text] [Related]

  • 14. Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth.
    Thijssen VL, Paulis YW, Nowak-Sliwinska P, Deumelandt KL, Hosaka K, Soetekouw PM, Cimpean AM, Raica M, Pauwels P, van den Oord JJ, Tjan-Heijnen VC, Hendrix MJ, Heldin CH, Cao Y, Griffioen AW.
    J Pathol; 2018 Dec 22; 246(4):447-458. PubMed ID: 30101525
    [Abstract] [Full Text] [Related]

  • 15. The pericyte and stromal cell marker CD248 (endosialin) is required for efficient lymph node expansion.
    Lax S, Hardie DL, Wilson A, Douglas MR, Anderson G, Huso D, Isacke CM, Buckley CD.
    Eur J Immunol; 2010 Jul 22; 40(7):1884-9. PubMed ID: 20432232
    [Abstract] [Full Text] [Related]

  • 16. No PDGF receptor signal in pericytes without endosialin?
    Demoulin JB.
    Cancer Biol Ther; 2010 Jun 01; 9(11):916-8. PubMed ID: 20473030
    [No Abstract] [Full Text] [Related]

  • 17. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization.
    Dell S, Peters S, Müther P, Kociok N, Joussen AM.
    Invest Ophthalmol Vis Sci; 2006 May 01; 47(5):1928-37. PubMed ID: 16639000
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
    Schellinger IN, Cordasic N, Panesar J, Buchholz B, Jacobi J, Hartner A, Klanke B, Jakubiczka-Smorag J, Burzlaff N, Heinze E, Warnecke C, Raaz U, Willam C, Tsao PS, Eckardt KU, Amann K, Hilgers KF.
    Kidney Int; 2017 Mar 01; 91(3):616-627. PubMed ID: 27927598
    [Abstract] [Full Text] [Related]

  • 19. Tumor Endothelial Marker 1 (TEM1/Endosialin/CD248) Enhances Wound Healing by Interacting with Platelet-Derived Growth Factor Receptors.
    Hong YK, Lee YC, Cheng TL, Lai CH, Hsu CK, Kuo CH, Hsu YY, Li JT, Chang BI, Ma CY, Lin SW, Wang KC, Shi GY, Wu HL.
    J Invest Dermatol; 2019 Oct 01; 139(10):2204-2214.e7. PubMed ID: 30986375
    [Abstract] [Full Text] [Related]

  • 20. Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.
    Kinoshita K, Nakagawa K, Hamada J, Hida Y, Tada M, Kondo S, Moriuchi T.
    Int J Oncol; 2010 Oct 01; 37(4):869-77. PubMed ID: 20811709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.